Cargando…
Leveraging the Global Influenza Surveillance and Response System for global respiratory syncytial virus surveillance—opportunities and challenges
BACKGROUND: Respiratory syncytial virus (RSV)‐associated acute lower respiratory infection is a common cause for hospitalization and hospital deaths in young children globally. There is urgent need to generate evidence to inform immunization policies when RSV vaccines become available. The WHO pilot...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578328/ https://www.ncbi.nlm.nih.gov/pubmed/31444997 http://dx.doi.org/10.1111/irv.12672 |
_version_ | 1783598340846387200 |
---|---|
author | Broor, Shobha Campbell, Harry Hirve, Siddhivinayak Hague, Siri Jackson, Sandra Moen, Ann Nair, Harish Palekar, Rakhee Rajatonirina, Soatiana Smith, Peter G Venter, Marietjie Wairagkar, Niteen Zambon, Maria Ziegler, Thedi Zhang, Wenqing |
author_facet | Broor, Shobha Campbell, Harry Hirve, Siddhivinayak Hague, Siri Jackson, Sandra Moen, Ann Nair, Harish Palekar, Rakhee Rajatonirina, Soatiana Smith, Peter G Venter, Marietjie Wairagkar, Niteen Zambon, Maria Ziegler, Thedi Zhang, Wenqing |
author_sort | Broor, Shobha |
collection | PubMed |
description | BACKGROUND: Respiratory syncytial virus (RSV)‐associated acute lower respiratory infection is a common cause for hospitalization and hospital deaths in young children globally. There is urgent need to generate evidence to inform immunization policies when RSV vaccines become available. The WHO piloted a RSV surveillance strategy that leverages the existing capacities of the Global Influenza Surveillance and Response System (GISRS) to better understand RSV seasonality, high‐risk groups, validate case definitions, and develop laboratory and surveillance standards for RSV. METHODS: The RSV sentinel surveillance strategy was piloted in 14 countries. Patients across all age groups presenting to sentinel hospitals and clinics were screened all year‐round using extended severe acute respiratory infection (SARI) and acute respiratory infection (ARI) case definitions for hospital and primary care settings, respectively. Respiratory specimens were tested for RSV at the National Influenza Centre (NIC) using standardized molecular diagnostics that had been validated by an External Quality Assurance program. The WHO FluMart data platform was adapted to receive case‐based RSV data and visualize interactive visualization outputs. RESULTS: Laboratory standards for detecting RSV by RT‐PCR were developed. A review assessed the feasibility and the low incremental costs for RSV surveillance. Several challenges were addressed related to case definitions, sampling strategies, the need to focus surveillance on young children, and the data required for burden estimation. CONCLUSIONS: There was no evidence of any significant adverse impact on the functioning of GISRS which is primarily intended for virologic and epidemiological surveillance of influenza. |
format | Online Article Text |
id | pubmed-7578328 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75783282020-11-01 Leveraging the Global Influenza Surveillance and Response System for global respiratory syncytial virus surveillance—opportunities and challenges Broor, Shobha Campbell, Harry Hirve, Siddhivinayak Hague, Siri Jackson, Sandra Moen, Ann Nair, Harish Palekar, Rakhee Rajatonirina, Soatiana Smith, Peter G Venter, Marietjie Wairagkar, Niteen Zambon, Maria Ziegler, Thedi Zhang, Wenqing Influenza Other Respir Viruses Original Articles BACKGROUND: Respiratory syncytial virus (RSV)‐associated acute lower respiratory infection is a common cause for hospitalization and hospital deaths in young children globally. There is urgent need to generate evidence to inform immunization policies when RSV vaccines become available. The WHO piloted a RSV surveillance strategy that leverages the existing capacities of the Global Influenza Surveillance and Response System (GISRS) to better understand RSV seasonality, high‐risk groups, validate case definitions, and develop laboratory and surveillance standards for RSV. METHODS: The RSV sentinel surveillance strategy was piloted in 14 countries. Patients across all age groups presenting to sentinel hospitals and clinics were screened all year‐round using extended severe acute respiratory infection (SARI) and acute respiratory infection (ARI) case definitions for hospital and primary care settings, respectively. Respiratory specimens were tested for RSV at the National Influenza Centre (NIC) using standardized molecular diagnostics that had been validated by an External Quality Assurance program. The WHO FluMart data platform was adapted to receive case‐based RSV data and visualize interactive visualization outputs. RESULTS: Laboratory standards for detecting RSV by RT‐PCR were developed. A review assessed the feasibility and the low incremental costs for RSV surveillance. Several challenges were addressed related to case definitions, sampling strategies, the need to focus surveillance on young children, and the data required for burden estimation. CONCLUSIONS: There was no evidence of any significant adverse impact on the functioning of GISRS which is primarily intended for virologic and epidemiological surveillance of influenza. John Wiley and Sons Inc. 2019-08-24 2020-11 /pmc/articles/PMC7578328/ /pubmed/31444997 http://dx.doi.org/10.1111/irv.12672 Text en © 2019 The World Health Organization. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Broor, Shobha Campbell, Harry Hirve, Siddhivinayak Hague, Siri Jackson, Sandra Moen, Ann Nair, Harish Palekar, Rakhee Rajatonirina, Soatiana Smith, Peter G Venter, Marietjie Wairagkar, Niteen Zambon, Maria Ziegler, Thedi Zhang, Wenqing Leveraging the Global Influenza Surveillance and Response System for global respiratory syncytial virus surveillance—opportunities and challenges |
title | Leveraging the Global Influenza Surveillance and Response System for global respiratory syncytial virus surveillance—opportunities and challenges |
title_full | Leveraging the Global Influenza Surveillance and Response System for global respiratory syncytial virus surveillance—opportunities and challenges |
title_fullStr | Leveraging the Global Influenza Surveillance and Response System for global respiratory syncytial virus surveillance—opportunities and challenges |
title_full_unstemmed | Leveraging the Global Influenza Surveillance and Response System for global respiratory syncytial virus surveillance—opportunities and challenges |
title_short | Leveraging the Global Influenza Surveillance and Response System for global respiratory syncytial virus surveillance—opportunities and challenges |
title_sort | leveraging the global influenza surveillance and response system for global respiratory syncytial virus surveillance—opportunities and challenges |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578328/ https://www.ncbi.nlm.nih.gov/pubmed/31444997 http://dx.doi.org/10.1111/irv.12672 |
work_keys_str_mv | AT broorshobha leveragingtheglobalinfluenzasurveillanceandresponsesystemforglobalrespiratorysyncytialvirussurveillanceopportunitiesandchallenges AT campbellharry leveragingtheglobalinfluenzasurveillanceandresponsesystemforglobalrespiratorysyncytialvirussurveillanceopportunitiesandchallenges AT hirvesiddhivinayak leveragingtheglobalinfluenzasurveillanceandresponsesystemforglobalrespiratorysyncytialvirussurveillanceopportunitiesandchallenges AT haguesiri leveragingtheglobalinfluenzasurveillanceandresponsesystemforglobalrespiratorysyncytialvirussurveillanceopportunitiesandchallenges AT jacksonsandra leveragingtheglobalinfluenzasurveillanceandresponsesystemforglobalrespiratorysyncytialvirussurveillanceopportunitiesandchallenges AT moenann leveragingtheglobalinfluenzasurveillanceandresponsesystemforglobalrespiratorysyncytialvirussurveillanceopportunitiesandchallenges AT nairharish leveragingtheglobalinfluenzasurveillanceandresponsesystemforglobalrespiratorysyncytialvirussurveillanceopportunitiesandchallenges AT palekarrakhee leveragingtheglobalinfluenzasurveillanceandresponsesystemforglobalrespiratorysyncytialvirussurveillanceopportunitiesandchallenges AT rajatonirinasoatiana leveragingtheglobalinfluenzasurveillanceandresponsesystemforglobalrespiratorysyncytialvirussurveillanceopportunitiesandchallenges AT smithpeterg leveragingtheglobalinfluenzasurveillanceandresponsesystemforglobalrespiratorysyncytialvirussurveillanceopportunitiesandchallenges AT ventermarietjie leveragingtheglobalinfluenzasurveillanceandresponsesystemforglobalrespiratorysyncytialvirussurveillanceopportunitiesandchallenges AT wairagkarniteen leveragingtheglobalinfluenzasurveillanceandresponsesystemforglobalrespiratorysyncytialvirussurveillanceopportunitiesandchallenges AT zambonmaria leveragingtheglobalinfluenzasurveillanceandresponsesystemforglobalrespiratorysyncytialvirussurveillanceopportunitiesandchallenges AT zieglerthedi leveragingtheglobalinfluenzasurveillanceandresponsesystemforglobalrespiratorysyncytialvirussurveillanceopportunitiesandchallenges AT zhangwenqing leveragingtheglobalinfluenzasurveillanceandresponsesystemforglobalrespiratorysyncytialvirussurveillanceopportunitiesandchallenges |